Log in to your Inderes Free account to see all free content on this page.
Egetis Therapeutics
5.84 SEK
-1.18 %
Less than 1K followers
EGTX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.18 %
+17.74 %
+21.41 %
+9.36 %
+2.10 %
+48.22 %
-30.97 %
+0.55 %
-57.79 %
Egetis Therapeutics is a pharmaceutical company focused on developing innovative treatments for rare diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business has a global presence and serves customers worldwide. Egetis Therapeutics was founded in 2006 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
2.48B SEK
Turnover
3.55M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
29.4.
2026
Interim report Q1'26
21.8.
2026
Interim report Q2'26
6.11.
2026
Interim report Q3'26
All
Webcasts
Press releases
ShowingAll content types
Egetis Therapeutics has successfully carried out a directed share issue amounting to SEK 350 million (approximately USD 38 million)
Egetis Therapeutics announces the intention to carry out a directed share issue of approximately SEK 350 million (approximately USD 38 million)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
